FAM13A and pulmonary arterial hypertension: Given that Fam13a was reduced in the lungs of mice with pulmonary hypertension, and genetic loss of FAM13A exacerbated pulmonary hypertension, enhancing and/or preserving FAM13A in the lungs might have a therapeutic potential.